CME Bridge List

This interactive learning environment will help you visualize and apply updates in frontline management of advanced melanoma. New combinations and targets in immune checkpoint inhibitor (ICI)-based therapy are changing first-line therapy for many patients with unresectable or metastatic melanoma. This interactive audiovisual experience will reinforce your understanding of latest data from clinical trials of immunotherapy for melanoma, highlight potential adverse events associated with treatment, and illustrate the importance of patient-centered, multidisciplinary care. Join us today to explore the use of ICIs for advanced melanoma management from a new perspective.

RELEASED DATE: August 29, 2025
EXPIRATION DATE: August 29, 2026

This online program is designed to help oncologists, dermatologists, nurse practitioners, oncology pharmacists, and physician's assistants to ensure confidence in the management of advanced melanoma. We aim to evaluate the pathophysiology of melanoma, including the rationale for use of anti-LAG3 antibodies in combination in advanced melanoma; assess the latest clinical data and clinical trial opportunities concerning the use of anti-LAG3 antibodies for combination in advanced melanoma; and recognize safety data with combination immunotherapy approaches in advanced melanoma.

RELEASED DATE: March 03, 2023
EXPIRATION DATE: March 03, 2024